Allera Health Products - Immune Extra All Natural with Proligna Pine Cone Extract - 60 Vegetarian Capsules
Allera’s first product, ImmunExtra, is the only supplement that contains Proligna, an all natural, preservative-free, patented, botanical compound first studied in Japan and developed by scientists at the Tampa Bay Research Institute in Florida.
ImmunExtra comes to market after more than 15 years of rigorous research on the pinecone extract that is the basis for Proligna. Extensive research indicates that pinecone extract optimizes immune cell activity to help the body combat germs and viruses that may cause illnesses. Stress, poor diet, lack of sleep, even medication can reduce your immune system's ability to work at its peak.
Allera Health Products - Immune Extra All Natural with Prolinga Pine Cone Extract Contains:
- No Sugar
- No Dairy
- No Nuts
- No Wheat
- No Soy
- No Yeast
- No Animal Products
- No Aritificial Colors
- No Flavors
ImmunExtra is an all natural, vegetarian, clinically-tested supplement containing
Proligna, a botanical extract derived from pine cones that optimizes your immune system.
Your Immune System
Like nature, your body has the natural ability to protect and heal itself; it happens through your immune system. Research shows a healthy immune system helps prevent most common illnesses. However, stress, poor diet, lack of sleep and even medications can reduce your immune system’s ability to work at its best.
In addition, the immune system’s effectiveness increases from birth until the teenage years, but then undergoes a subtle decline throughout the rest of your life. This decline leads to impairment in coping with infectious agents that can cause disease and illness.ProlignaImmunExtra
is the only immune product containing patented Proligna, a natural water extract of pinecones that has been shown to enhance the production of human dendritic cells 9 fold in 9 days. More recently, laboratory research has shown that Immunextra reduces the The arm of the immune system while at the same time promoting the Th1 arm of the immune system.
The health benefits of pinecone extract were first documented in 500 A.D. by the Greeks. Since that time, the extract has been used in modern day Japan, where it has long been associated with an increase in health and longevity. Try it to stay healthy. It is one of the only supplements tested to be safe in human studies at three independent medical centers in the United States.Quality and ScienceProligna
is made from fresh, clean pinecones harvested from Wisconsin forests. A patented method extracts the desirable molecules; the liquid extract is then tested extensively to ensure it is contaminant-free. It is gently dried to a powder that is used to make vegetarian ImmunExtra capsules.
Allera Health Products believes that quality ingredients and strict control of manufacturing and packaging are essential to product quality and efficacy. Immunextra is packaged in National Sanitation Foundation certified facilities that employ FDA Good Manufacturing Practices. 30 peer reviewed scientific publications describe the research performed on PPC.
About Allera Health
Allera Health Products, Inc. is a research and development company dedicated to providing innovative, natural products that enhance the immune system. Headquartered in St. Petersburg, Florida, the biotechnology company was founded in 2005. Allera holds the exclusive license for Proligna, developed by scientists at the Tampa Bay Research Institute. ImmunExtra is the first product based on this breakthrough compound; research continues to determine its true potential.
CEO Frank Tufaro, Ph.D. is a former professor of microbiology and virology at the University of British Columbia. During his 17-year tenure, he published extensively in the areas of virology and cancer. Frank was one of the original founders of Neurovir, Inc., a Vancouver-based biotech company with a mission to develop herpes-simplex virus oncolytic vectors for treating cancer. Frank initially served as Chief Scientific Officer, where he managed all aspects of drug development, including FDA interactions and contract manufacturing. He then served as CEO, during which time he negotiated and executed the successful merger of NeuroVir with MediGene AG, a public company headquartered in Munich, Germany.
Following the merger, Frank was appointed the Managing Director of the U.S. subsidiary of MediGene AG. In that capacity, he hired and led a team of 15 Directors and VPs, including representatives from manufacturing and process development, pre-clinical, QA/QC, regulatory, clinical, and business development. Within 18 months, he developed MediGene, Inc. into a fully integrated drug development company of 55 employees located in two facilities in San Diego.
From MediGene, Frank worked with several biotech start-up companies to develop successful financing and product development strategies. Frank remains active in both the business and scientific arenas. He serves on the Scientific Advisory Boards of several public and private companies.